Pharmaceuticals
"Top 20 global biopharmaceutical innovator advancing health for all."
Boehringer Ingelheim is ranked among the top 20 pharmaceutical companies globally, with approximately 50,000 employees dedicated to advancing innovation across three key sectors: human pharmaceuticals, animal health, and biopharmaceuticals. Driven by a commitment to enhancing the well-being of both humans and animals, the company prioritizes research in areas lacking effective treatments, aiming to improve health and quality of life. By focusing on pioneering therapies, Boehringer Ingelheim seeks to extend patient survival and deliver transformative solutions. In the field of animal health, the company is recognized for its cutting-edge preventive care solutions.